Ontario Regulation 460/22
made under the
Pharmacy Act, 1991
Made: April 25, 2022 Approved: April 28, 2022 Filed: May 3, 2022 Published on e-Laws: May 3, 2022 Printed in The Ontario Gazette: May 21, 2022
Amending O. Reg. 202/94
(GENERAL)
1. (1) Subsection 35 (1) of Ontario Regulation 202/94 is revoked and the following substituted:
(1) For the purposes of paragraph 3 of subsection 4 (1) of the Act, a member referred to in subsection (3) who complies with the other requirements of this section is authorized to prescribe the following drugs:
1. For the sole purpose of smoking cessation, the following specified drugs:
i. Varenicline Tartrate.
ii. Bupropion Hydrochloride.
2. For the sole purpose of treating a minor ailment listed in Column 1 of the Table to Schedule 4, a drug in a class of drugs listed opposite the minor ailment in Column 2 of that Table.
(2) Subsection 35 (2) of the Regulation is revoked.
(3) Subsection 35 (4) of the Regulation is amended by striking out “and” at the end of clause (e), by adding “and” at the end of clause (f) and by adding the following clause:
(g) in the case of a drug referred to in paragraph 2 of subsection (1), has determined, through a therapeutic assessment, that the drug is the most appropriate treatment for the patient’s minor ailment.
2. Paragraph 2 of section 38 of the Regulation is amended by adding “clause 35 (4) (d) or” before “paragraph 4 of subsection 36 (4)”.
3. The Regulation is amended by adding the following Schedule:
Schedule 4 DrugS — Minor Ailments
(Arranged by American Hospital Formulary Service (AHFS) Pharmacologic-Therapeutic Classification)
Item


Column 1 Minor Ailment


Column 2 AHFS Classification
1.


Allergic rhinitis


4:08 Second Generation Antihistamines 52:02 Eye, Ear, Nose and Throat (EENT) Preparations — Antiallergic Agents 52:08.08 Eye, Ear, Nose and Throat (EENT) Preparations — Anti-inflammatory Agents — Corticosteroids
2.


Candidal stomatitis


8:14.28 Anti-infectives — Antifungals — Polyenes
3.


Conjunctivitis (bacterial, allergic or viral)


04:04.20 Propylamine Derivatives 52:32 Eye, Ear, Nose and Throat (EENT) Preparations — Vasoconstrictors 52:04.04 Eye, Ear, Nose and Throat (EENT) Preparations — Anti-infectives — Antibacterials 52:02 Eye, Ear, Nose and Throat (EENT) Preparations — Antiallergic Agents
4.


Dermatitis (atopic/eczema, allergic or contact)


84:06 Skin and Mucous Membrane Agents — Anti-inflammatory Agents
5.


Dysmenorrhea


28:08.04 Central Nervous System Agents — Analgesics and Antipyretics — Nonsteroidal Anti-inflammatory Agents
6.


Gastroesophageal reflux disease (GERD)


56:04 Gastrointestinal Drugs — Antacids and Adsorbents 56:28.12 Gastrointestinal Drugs — Antiulcer Agents and Acid Suppressants — Histamine H2-Antagonists 56:28.36 Gastrointestinal Drugs — Antinuclear Agents and Acid Suppressants — Proton-Pump Inhibitors
7.


Hemorrhoids


12:12.04 Autonomic Drugs — Sympathomimetic (Adrenergic) Agents — Alpha-Adrenergic Agonists 52:04.92 Eye, Ear, Nose and Throat (EENT) Anti-infectives — Miscellaneous 84:06 Skin and Mucous Membrane Agents — Anti-inflammatory Agents 84:08 Skin and Mucous Membrane Agents — Antipruritics and Local Anesthetics 84:04.04 Skin and Mucous Membrane Agents — Anti-infectives — Antibacterials
8.


Herpes labialis


8:18.32 Anti-infective Agents — Antivirals — Nucleosides and Nucleotides 84:06 Skin and Mucous Member Agents — Anti-inflammatory Agents 84:04.06 Skin and Mucous Membrane Agents — Anti-infectives — Antivirals
9.


Impetigo


84:04.04 Skin and Mucous Membrane Agents — Anti-infectives — Antibacterials 84:06 Skin and Mucous Member Agents - Anti-inflammatory Agents
10.


Insect bites and urticaria


4:04 Antihistamine Drugs — First Generation Antihistamines 4:08 Antihistamine Drugs — Second Generation Antihistamines 84:06 Skin and Mucous Member Agents — Anti-inflammatory Agents 84:08 Skin and Mucous Membrane Agents — Antipruritics and Local Anesthetics
11.


Tick bites, post-exposure prophylaxis to prevent Lyme disease


8.12.24 Anti-infective Agents — Antibacterials — Tetracyclines
12.


Musculoskeletal sprains and strains


28:08.04 Central Nervous System Agents — Analgesics and Antipyretics — Nonsteroidal Anti-inflammatory Agents 28.08.92 Central Nervous System Agents — Analgesics and Antipyretics — Miscellaneous
13.


Urinary Tract Infection (uncomplicated)


8:12.20 Anti-infective Agents — Antibacterials — Sulfonamides 8:36 Anti-infective Agents — Urinary Anti-infectives
 
Commencement
4. This Regulation comes into force on the later of January 1, 2023 and the day this Regulation is filed.
Made by:
Council of the Ontario College of Pharmacists:
Billy Cheung
Chair, OCP Board
Susan James
Acting Registrar, Director Quality
Date made: April 25, 2022